Our collaborative study with Dr. Beauchamp’s group leading to the discovery of NFATc1 as an invasive driver in colon cancer has been published in Cancer Research in a paper entitled Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.
News Story